Notably, TP53, a critical tumor suppressor gene, showed a mutation rate of 36% in the high-risk group compared to 21% in the low-risk group, indicating accelerated tumor proliferation and poorer prognosis in the high-risk group. This evidence concerns the gene TP53 and neoplasm.